Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testosterone replacement therapy for late-onset hypogonadism.

Glenn R Cunningham1

  • 1Baylor College of Medicine, St Luke's Episcopal Hospital, Houston, TX 77030, USA. glennc@bcm.tmc.edu

Nature Clinical Practice. Urology
|May 13, 2006
PubMed
Summary

Testosterone levels decline with age, increasing the number of hypogonadal men. Testosterone replacement therapy (TRT) may benefit some aging men, but caution and further research are needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial.

JAMA network open·2023
Same author

Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism.

The Journal of clinical endocrinology and metabolism·2023
Same author

Cardiovascular Safety of Testosterone-Replacement Therapy.

The New England journal of medicine·2023
Same author

Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE study.

American heart journal·2021
Same author

Biomarkers and Noncalcified Coronary Artery Plaque Progression in Older Men Treated With Testosterone.

The Journal of clinical endocrinology and metabolism·2019
Same author

Prostate-Specific Antigen Levels During Testosterone Treatment of Hypogonadal Older Men: Data from a Controlled Trial.

The Journal of clinical endocrinology and metabolism·2019

Area of Science:

  • Endocrinology
  • Geriatrics
  • Men's Health

Background:

  • Testosterone levels naturally decrease with aging.
  • Low testosterone (hypogonadism) affects a significant percentage of older men.
  • Symptoms of testosterone deficiency are observed in aging men.

Purpose of the Study:

  • To review the current understanding of age-related testosterone decline.
  • To evaluate the potential benefits and risks of testosterone replacement therapy (TRT) in aging men.
  • To highlight the need for further clinical trials on TRT efficacy and safety in older populations.

Main Methods:

  • Review of cross-sectional and longitudinal studies on testosterone levels in aging men.
  • Analysis of existing small studies on testosterone replacement therapy (TRT) outcomes.
  • Discussion of the prevalence and clinical implications of late-onset hypogonadism.

Main Results:

  • Testosterone levels decline with age, with increasing prevalence of hypogonadism in older men.
  • Small studies suggest potential benefits of TRT in some aging men, but results are inconsistent.
  • TRT may be safer and more effective in men younger than 65 compared to older men.

Conclusions:

  • The aging male population is projected to see an increase in hypogonadism.
  • Cautious approach and close monitoring are essential when considering TRT for aging men.
  • Large-scale clinical trials are required to establish definitive safety and efficacy of TRT in different age groups of aging men.

Related Experiment Videos